← Back to Search

Dietary Supplement

young women with MetS for Metabolic Syndrome (FEMMES II Trial)

N/A
Waitlist Available
Led By Pathmaja Paramsothy, MD, MS
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 1/2 hours
Awards & highlights

FEMMES II Trial Summary

Among 10 premenopausal women with Metabolic Syndrome: Specific Aim 1: Compare the effects of acute fat feeding on flow mediated dilation (FMD) as measured by brachial artery reactivity among three fat challenges (saturated fat vs. monounsaturated fat (MUFA) vs. polyunsaturated fat (PUFA)at 4 hours post feeding. Hypothesis Saturated fat feeding will impair FMD but MUFA and PUFA feeding will not. Specific Aim 2: Compare the effects of acute feeding on vascular inflammation as measured by VCAM and sICAM among three fat challenges at 3 1/2 hours post feeding. Hypothesis: Saturated fat feeding will increase vascular inflammation but MUFA and PUFA will not.

Eligible Conditions
  • Metabolic Syndrome

FEMMES II Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~four hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and four hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Flow Mediated Dilation at 4 hours post feeding
Secondary outcome measures
Adhesion molecules (VCAM and sICAM)

FEMMES II Trial Design

1Treatment groups
Experimental Treatment
Group I: young women with MetSExperimental Treatment1 Intervention
Saturated fat (control) n-3 Polyunsaturated fat (experimental) monounsaturated fat

Find a Location

Who is running the clinical trial?

University of WashingtonLead Sponsor
1,738 Previous Clinical Trials
1,844,341 Total Patients Enrolled
8 Trials studying Metabolic Syndrome
728 Patients Enrolled for Metabolic Syndrome
Pathmaja Paramsothy, MD, MSPrincipal InvestigatorUniversity of Washington

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Fat Effects in Women With Metabolic Syndrome
2010. "Fat Effects in Women With Metabolic Syndrome". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01093560.
All > Osteopenia
~1 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top